| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Cervical Neoplasms | 11 | 2023 | 296 | 4.040 |
Why?
|
| Uterine Cervical Dysplasia | 5 | 2023 | 33 | 2.360 |
Why?
|
| Cervix Uteri | 4 | 2016 | 71 | 1.440 |
Why?
|
| Papillomavirus Infections | 4 | 2023 | 264 | 1.410 |
Why?
|
| Endometrial Neoplasms | 5 | 2022 | 208 | 1.080 |
Why?
|
| Genital Neoplasms, Female | 1 | 2023 | 108 | 0.760 |
Why?
|
| Gynecology | 1 | 2023 | 130 | 0.730 |
Why?
|
| Carcinoma, Endometrioid | 2 | 2017 | 49 | 0.660 |
Why?
|
| Early Detection of Cancer | 4 | 2023 | 422 | 0.650 |
Why?
|
| Biopsy, Fine-Needle | 5 | 2017 | 107 | 0.640 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2016 | 4 | 0.550 |
Why?
|
| Conization | 1 | 2016 | 1 | 0.540 |
Why?
|
| Squamous Intraepithelial Lesions of the Cervix | 1 | 2016 | 1 | 0.540 |
Why?
|
| Glomus Tumor | 1 | 2016 | 9 | 0.530 |
Why?
|
| Diagnostic Errors | 2 | 2016 | 160 | 0.510 |
Why?
|
| Emperipolesis | 1 | 2015 | 2 | 0.490 |
Why?
|
| Cytodiagnosis | 3 | 2023 | 46 | 0.490 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2015 | 16 | 0.480 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 24 | 0.480 |
Why?
|
| Papanicolaou Test | 1 | 2014 | 39 | 0.470 |
Why?
|
| RNA-Binding Proteins | 2 | 2014 | 280 | 0.460 |
Why?
|
| Lymph Nodes | 3 | 2022 | 550 | 0.450 |
Why?
|
| Specimen Handling | 1 | 2014 | 103 | 0.450 |
Why?
|
| Atypical Squamous Cells of the Cervix | 1 | 2013 | 2 | 0.440 |
Why?
|
| Biomarkers, Tumor | 4 | 2013 | 1545 | 0.430 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 75 | 0.410 |
Why?
|
| Female | 26 | 2024 | 46602 | 0.390 |
Why?
|
| Neurofibromatosis 1 | 1 | 2012 | 39 | 0.390 |
Why?
|
| Papillomaviridae | 2 | 2023 | 156 | 0.340 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2007 | 103 | 0.330 |
Why?
|
| Histiocytosis, Sinus | 1 | 2009 | 15 | 0.330 |
Why?
|
| Humans | 34 | 2024 | 89985 | 0.320 |
Why?
|
| Immunohistochemistry | 6 | 2021 | 1801 | 0.310 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2009 | 117 | 0.300 |
Why?
|
| Vaccination | 2 | 2023 | 279 | 0.300 |
Why?
|
| Vaginal Smears | 2 | 2023 | 71 | 0.290 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2007 | 17 | 0.280 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 1396 | 0.280 |
Why?
|
| Middle Aged | 16 | 2021 | 26159 | 0.270 |
Why?
|
| Goiter, Nodular | 1 | 2006 | 7 | 0.260 |
Why?
|
| Thyroid Nodule | 2 | 2008 | 62 | 0.260 |
Why?
|
| Stromal Cells | 1 | 2007 | 151 | 0.260 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 159 | 0.260 |
Why?
|
| Carcinoma | 2 | 2006 | 438 | 0.250 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2006 | 55 | 0.250 |
Why?
|
| Ovarian Neoplasms | 2 | 2022 | 772 | 0.240 |
Why?
|
| Thyroid Neoplasms | 2 | 2008 | 426 | 0.240 |
Why?
|
| Esophagus | 2 | 2024 | 107 | 0.240 |
Why?
|
| Klinefelter Syndrome | 1 | 2004 | 5 | 0.230 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 1255 | 0.230 |
Why?
|
| Thyroid Gland | 1 | 2006 | 280 | 0.230 |
Why?
|
| Esophagectomy | 1 | 2024 | 91 | 0.230 |
Why?
|
| Stem Cell Transplantation | 2 | 2024 | 189 | 0.230 |
Why?
|
| Pregnancy | 3 | 2023 | 3046 | 0.220 |
Why?
|
| Anastomotic Leak | 1 | 2024 | 104 | 0.220 |
Why?
|
| Mass Screening | 2 | 2023 | 647 | 0.210 |
Why?
|
| Colposcopy | 1 | 2023 | 16 | 0.210 |
Why?
|
| Adipose Tissue | 2 | 2024 | 262 | 0.210 |
Why?
|
| Granulosa Cell Tumor | 1 | 2022 | 3 | 0.200 |
Why?
|
| Self-Directed Learning as Topic | 1 | 2021 | 2 | 0.200 |
Why?
|
| Skin Neoplasms | 1 | 2007 | 598 | 0.190 |
Why?
|
| Telomerase | 1 | 2022 | 67 | 0.190 |
Why?
|
| Lymphatic Metastasis | 4 | 2022 | 495 | 0.190 |
Why?
|
| Pathology | 1 | 2021 | 32 | 0.190 |
Why?
|
| Cystadenoma, Papillary | 1 | 2021 | 9 | 0.190 |
Why?
|
| Quality Assurance, Health Care | 1 | 2023 | 225 | 0.190 |
Why?
|
| Endometrial Stromal Tumors | 1 | 2020 | 5 | 0.180 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2020 | 16 | 0.180 |
Why?
|
| Sarcoma, Ewing | 2 | 2014 | 44 | 0.180 |
Why?
|
| Lymph Node Excision | 2 | 2022 | 220 | 0.160 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2021 | 182 | 0.160 |
Why?
|
| Stem Cells | 1 | 2021 | 376 | 0.160 |
Why?
|
| Kidney | 1 | 2004 | 1148 | 0.160 |
Why?
|
| Stents | 1 | 2021 | 412 | 0.150 |
Why?
|
| Adult | 13 | 2022 | 26827 | 0.150 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2018 | 19 | 0.150 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 2018 | 0.150 |
Why?
|
| Curettage | 2 | 2014 | 14 | 0.150 |
Why?
|
| Bone Neoplasms | 2 | 2014 | 321 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2021 | 333 | 0.140 |
Why?
|
| Uterine Neoplasms | 1 | 2020 | 250 | 0.130 |
Why?
|
| Aged | 6 | 2017 | 19262 | 0.130 |
Why?
|
| Thoracentesis | 1 | 2015 | 3 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 3022 | 0.120 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2014 | 21 | 0.120 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 49 | 0.120 |
Why?
|
| Gene Fusion | 1 | 2014 | 42 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2023 | 105 | 0.110 |
Why?
|
| Minichromosome Maintenance Proteins | 1 | 2013 | 3 | 0.110 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2013 | 22 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2015 | 690 | 0.110 |
Why?
|
| Staining and Labeling | 1 | 2013 | 169 | 0.110 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 1606 | 0.110 |
Why?
|
| Skull Base Neoplasms | 1 | 2012 | 14 | 0.100 |
Why?
|
| Neuroendoscopy | 1 | 2012 | 18 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 1732 | 0.100 |
Why?
|
| Meningioma | 1 | 2012 | 62 | 0.100 |
Why?
|
| Nasal Mucosa | 1 | 2012 | 191 | 0.100 |
Why?
|
| Male | 11 | 2021 | 42690 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 784 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 334 | 0.090 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 222 | 0.090 |
Why?
|
| Automation, Laboratory | 1 | 2010 | 12 | 0.090 |
Why?
|
| False Negative Reactions | 1 | 2010 | 63 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 740 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 980 | 0.090 |
Why?
|
| Gene Expression | 1 | 2013 | 1309 | 0.080 |
Why?
|
| Hyperplasia | 1 | 2008 | 152 | 0.080 |
Why?
|
| Keratin-20 | 1 | 2007 | 7 | 0.070 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2007 | 41 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1243 | 0.070 |
Why?
|
| Mucin-1 | 1 | 2007 | 44 | 0.070 |
Why?
|
| Carcinoma, Papillary | 1 | 2008 | 156 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2022 | 9216 | 0.070 |
Why?
|
| Axilla | 1 | 2007 | 103 | 0.070 |
Why?
|
| Arm | 1 | 2007 | 99 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2013 | 2886 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 124 | 0.070 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2006 | 2 | 0.070 |
Why?
|
| Endosonography | 1 | 2007 | 99 | 0.070 |
Why?
|
| Ulna | 1 | 2006 | 15 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2006 | 23 | 0.070 |
Why?
|
| Galectin 3 | 1 | 2006 | 20 | 0.060 |
Why?
|
| Pennsylvania | 1 | 2006 | 95 | 0.060 |
Why?
|
| Tissue Array Analysis | 1 | 2006 | 126 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 123 | 0.060 |
Why?
|
| Scapula | 1 | 2005 | 24 | 0.060 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2004 | 7 | 0.060 |
Why?
|
| Paneth Cells | 1 | 2004 | 10 | 0.060 |
Why?
|
| Ampulla of Vater | 1 | 2004 | 23 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 6785 | 0.060 |
Why?
|
| Femur | 1 | 2005 | 112 | 0.060 |
Why?
|
| Osteosarcoma | 1 | 2005 | 161 | 0.060 |
Why?
|
| Karyotyping | 1 | 2004 | 252 | 0.060 |
Why?
|
| Anastomosis, Surgical | 1 | 2024 | 277 | 0.050 |
Why?
|
| Swine | 1 | 2024 | 590 | 0.050 |
Why?
|
| Pain | 1 | 2006 | 399 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2023 | 67 | 0.050 |
Why?
|
| Ischemia | 1 | 2024 | 253 | 0.050 |
Why?
|
| Ribonuclease III | 1 | 2022 | 16 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 258 | 0.050 |
Why?
|
| Young Adult | 1 | 2014 | 6415 | 0.050 |
Why?
|
| Academic Performance | 1 | 2021 | 7 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2022 | 64 | 0.050 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2021 | 19 | 0.050 |
Why?
|
| Epigenomics | 1 | 2022 | 103 | 0.050 |
Why?
|
| Microscopy | 1 | 2021 | 87 | 0.050 |
Why?
|
| Oncogene Fusion | 1 | 2020 | 10 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2022 | 2000 | 0.040 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2020 | 19 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 511 | 0.040 |
Why?
|
| Point Mutation | 1 | 2021 | 246 | 0.040 |
Why?
|
| Ovary | 1 | 2021 | 262 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 294 | 0.040 |
Why?
|
| Internet | 1 | 2021 | 323 | 0.040 |
Why?
|
| Wound Healing | 1 | 2021 | 361 | 0.040 |
Why?
|
| Triage | 1 | 2019 | 117 | 0.040 |
Why?
|
| United States | 1 | 2010 | 7114 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 521 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 869 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 2395 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 490 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2006 | 4329 | 0.040 |
Why?
|
| Curriculum | 1 | 2021 | 573 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 1704 | 0.030 |
Why?
|
| Risk Factors | 1 | 2006 | 5562 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 4048 | 0.030 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2014 | 8 | 0.030 |
Why?
|
| Prognosis | 1 | 2022 | 3800 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2014 | 8277 | 0.030 |
Why?
|
| Genotype | 1 | 2019 | 1852 | 0.030 |
Why?
|
| Bone Transplantation | 1 | 2014 | 67 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2014 | 69 | 0.030 |
Why?
|
| Animals | 2 | 2024 | 27536 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2014 | 177 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 1066 | 0.030 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2012 | 8 | 0.030 |
Why?
|
| Skull Base | 1 | 2012 | 48 | 0.030 |
Why?
|
| DNA | 1 | 2018 | 1311 | 0.020 |
Why?
|
| Neoplasms | 1 | 2007 | 3067 | 0.020 |
Why?
|
| Mutation | 1 | 2022 | 4169 | 0.020 |
Why?
|
| Adolescent | 3 | 2008 | 9345 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 1145 | 0.020 |
Why?
|
| Digestive System Neoplasms | 1 | 2007 | 21 | 0.020 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2007 | 44 | 0.020 |
Why?
|
| Mediastinal Neoplasms | 1 | 2007 | 46 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2005 | 69 | 0.020 |
Why?
|
| Totipotent Stem Cells | 1 | 2004 | 3 | 0.010 |
Why?
|
| CA-19-9 Antigen | 1 | 2004 | 12 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 231 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 2004 | 35 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2004 | 40 | 0.010 |
Why?
|
| Muramidase | 1 | 2004 | 35 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2004 | 68 | 0.010 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2004 | 58 | 0.010 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2004 | 83 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2006 | 3477 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 2004 | 162 | 0.010 |
Why?
|
| Biopsy | 1 | 2006 | 1184 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 538 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 3678 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2004 | 1533 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 2327 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 1185 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 5358 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 2677 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 2370 | 0.010 |
Why?
|